Desipramine Hydrochloride 25 MG Oral Tablet
INDICATIONS AND USAGE Desipramine hydrochloride tablets are indicated for the treatment of depression.
Actavis Pharma, Inc.
ROUND BLUE 342
342 ROUND BLUE
Related Pills
Desipramine Hydrochloride 150 MG Oral Tablet
actavis pharma, inc.
Desipramine Hydrochloride 50 MG Oral Tablet
Actavis Pharma, Inc.
Naproxen 500 MG Oral Tablet
Camber Pharmaceuticals
Naproxen 500 MG Oral Tablet
Camber Pharmaceuticals
Naproxen 500 MG Oral Tablet
Camber Pharmaceuticals
lamotrigine tablet extended release
torrent pharmaceuticals limited
naproxen tablet
camber pharmaceuticals
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED:
DESIPRAMINE HYDROCHLORIDE tablets, USP are supplied as follows: 10 mg – Each white to off-white, round, unscored, biconvex with flat edge, film-coated tablet, debossed with over 341 on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 45963-341-02) with a non-child resistant closure. 25 mg – Each light blue, round, unscored, biconvex with flat edge, film-coated tablet, debossed with over 342 on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 45963-342-02) with a non-child resistant closure. 50 mg - Each blue, round, unscored, biconvex with flat edge, film-coated tablet, debossed with over 343 on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 45963-343-02) with a non-child resistant closure. 75 mg – Each light blue, round, unscored, biconvex with flat edge, film-coated tablet, debossed with over 344 on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 45963-344-02) with a non-child resistant closure. 100 mg – Each blue, round, unscored, biconvex with flat edge, film-coated tablet, debossed with over 345 on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 45963-345-02) with a non-child resistant closure. 150 mg – Each white to off-white, round, unscored, biconvex with flat edge, film-coated tablet, debossed with over 346 on one side and plain on the other side. Tablets are supplied in bottles of 50 (NDC 45963-346-50) with a non-child resistant closure. Dispense in a tight, light-resistant container as defined in the USP. Preserve in tight container. Protect from excessive heat. Storage: Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from moisture. Dispense with Medication Guide available at: www.tevausa.com/medguides Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. B 12/2023 9d202fae-figure-02 9d202fae-figure-03 9d202fae-figure-04 9d202fae-figure-05 9d202fae-figure-06 9d202fae-figure-07
More pills like ROUND 342